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SUMMARY
Background and Aim
Dietary fat intake has long been associated with fatty liver. Our study aimed to
determine the effect of dietary fats on longitudinal fatty liver index (FLI) trajectories
from adolescence to young adulthood.
Methods:
Participants in the Raine Study had cross-sectional assessments at ages 14, 17, 20 and
22 years, during which anthropometric measurements and blood tests were obtained.
FLI trajectories were derived from the longitudinal FLI results. Dietary fat intake was
measured with a semi-quantitative food frequency questionnaire at 14 years and fatty
acid intake and composition was estimated.
Results:
Three FLI trajectories were identified and labelled as stable-low (79.1%, N=782), lowhigh (13.9%, N=132), and stable-high (7%, N=71). Long-chain polyunsaturated fatty
acids in the low to high group relative to the stable low group had a relative risk of 1.27
(95% CI 1.10-1.48). Compared to the stable low group, omega-6 and the ratio of
omega-6 to omega-3 in the stable high group were associated with an increased relative
risk of 1.34 (95% CI 1.02-1.76) and 1.10 (95% CI 1.03-1.16) respectively.
Conclusion:
Our study found that adolescence to young adulthood is an important period in the
progression of fatty liver. Dietary fat intake in early adolescence is associated with
subsequent fatty liver. High omega-6 fatty acid intake and a high ratio of omega-6 to

8
omega-3 appear to be associated with fatty liver risk. Diets comprising fewer foods
high in omega-6 or with a low N6: N3 fatty acid ratio may reduce the risk of fatty liver.

9

Introduction

The contribution of an unhealthy diet, including excessive fatty food, to development
of fatty liver has been described over nearly two centuries 1. Non-alcoholic fatty liver
disease (NAFLD) is the most common form of fatty liver disease (FLD), with an
estimated global prevalence of up to 24% 2and causes a substantial economic burden to
society 3. The influence of rising obesity prevalence

4,5

, sedentary lifestyle 6, and

unhealthy dietary patterns 7 on development of fatty liver has previously been reported
in adolescents and young adults. A Western dietary pattern incorporating a high dietary
fat intake is associated with NAFLD in adolescents

10

. Furthermore, dietary fats are

considered to affect the pathogenesis of fatty liver 8.

Although some observational studies

9,10

and dietary intervention studies

11-13

have

attempted to clarify the cross-sectional relationship between dietary fats and fatty liver,
there is no longitudinal study investigating the relationship between dietary fat intake
and fatty liver occurrence and development in adolescents and young adult populations.
In the Raine Study, a prospective association between the high-fat “Western dietary
pattern” and ultrasound detected NAFLD in adolescents was found 7. We sought to test
the hypothesis that high intake of dietary fat is prospectively associated with fatty liver
in adolescents and young adults.

The primary aim of this study was to examine the association between baseline dietary
fatty acids intake during early adolescence and subsequent longitudinal fatty liver
trajectories as measured by fatty liver index (FLI) from adolescence to young adulthood.
Non-invasive diagnostic models, such as FLI, (based on waist circumference, body
mass index (BMI) triglycerides and gamma-glutamyl-transferase) are considered to be
accurate and validated method of determining NAFLD in population-based

10
epidemiological studies

14

. To achieve our primary aim, we identified distinct FLI

trajectories from 14 to 22 years in the Raine Study and tested the association of early
dietary fats in adolescents with these trajectories.

Methods

Study population

We utilised data from the Raine Study, a longitudinal cohort study that started as a
randomised controlled trial to study the effects of frequent and repeated ultrasound
scans on pregnancy outcomes. The background and methods of the Raine Study have
previously been described 7. The original cohort of pregnant study participants (Gen1)
were recruited between 1989 and 1992, at between 16 and 20 weeks gestation, resulting
in 2868 live births. Follow up assessments of the offspring (Gen2) cohort has been
conducted approximately every 3 years.. Approximately 70% of the Gen2 participants
had remained actively involved in the study at the 22-year follow-up. Clinical,
biochemical and questionnaire data were collected from serial assessments during
antenatal/perinatal stages, infancy, childhood, adolescence and adulthood

15

.

Laboratory examination and physical measurement data from the 14, 17, 20 and 22year follow-ups of the cohort were used in this study (see Figure 2 for detailed
information on participant recruitment). Institutional ethics committee approval was
obtained from the University of Western Australia Human Research Ethics Committee.
Signed informed parental or primary carer consent during Gen1 pregnancy, Gen2
childhood and adolescence, and subsequently by Gen2 adolescents and young adults
were obtained before participation in each assessment.

Dietary fat intake assessment

11
Dietary fat intake at 14 years was obtained from a validated semi-quantitative food
frequency questionnaire (FFQ-14) developed by the Commonwealth Scientific and
Industrial Research Organisation (CSIRO) in Adelaide, Australia, as previously
described

16

and evaluated 17. The parents or primary carer completed the FFQ-14 as

being representative of usual dietary and nutrient intake in the previous 12 months 18.
The study nurse checked FFQ-14 responses during the clinical follow-up to clarify
responses. All data from the FFQ-14 were verified by CSIRO twice, and Australian
food composition data were applied to obtain estimates of usual food and nutrient
intakes

19

. These included estimates of macro and micronutrients, including specific

dietary fats 18 (TFA, total fatty acid; SFA, saturated fatty acid; PUFA, polyunsaturated
fatty acid; MUFA, monounsaturated fatty acid; total omega-3 fatty acids (including alinolenic acid and long-chain n-3 ), n-3; total omega-6 fatty acids (including alphalinolenic acid and linolenic acid ), n-6; long chain omega-3 PUFA (Eicosapentaenoic
Acid, EPA + Docosapentaenoic Acid, DPA + Docosahexaenoic Acid, DHA), LCPUFA;
and the ratio of total n-6 to total n-3 fatty acids, n-6:n-3). The FFQ-14 did not collect
dietary fish oil supplement intake.

Dietary misreporting

Dietary misreporting can contribute to measurement error in the analysis of diet-disease
relationships 20. Potential dietary misreporting in the Raine study was determined using
the Goldberg method

21

(supplementary text 1), which estimates the cut-offs for

plausible reporting based on energy intake relative to basal metabolic rate. These cutoff values classify study participants as under-, plausible- or over-reporters of dietary
intake. The method has been used widely to identify misreporting from dietary surveys
and studies 22. Because dietary underreporting may be strongly associated with the risk
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of overweight 23, we considered excluding under-reporters. However, excluding underreporters removes participants at the highest risk, reducing our sample size considerably.
We therefore created a categorical variable for misreporting where all participant data
were included in the analysis. This categorical variable for misreporting was included
as a covariate in our regression models. Similarly, when we summarise participants
dietary fat intake at baseline, there is a significant difference in the proportion of dietary
misreporting between trajectory groups. Therefore we show the dietary data for
plausible reporters only in Table 2, and data of the entire cohort with all categories of
dietary reporting included (shown in Supplementary Table 1).

Anthropometric and laboratory measurements

At all years, a trained research assistant weighed and measured participants in light
clothing for height and weight using a calibrated stadiometer and electronic chair scales.
Body mass index (BMI= weight (kg)/ square of the height (m2)) was calculated, and
subjects were categorised as underweight, normal weight, overweight, and obese using
the International Obesity Task Force (IOTF) criteria at 14 years 24,25. Blood was taken
by a phlebotomist at the home of the participants from an antecubital vein after an
overnight fast. Laboratory assessments were performed in the PathWest Laboratories,
Perth, for serum glucose, insulin, alanine transaminase (ALT), aspartate
aminotransferase (AST), gamma-glutamyl transferase (GGT), triglycerides (TG), total
cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), ferritin, transferrin saturation, high sensitivity C-reactive protein
(hs-CRP), adiponectin, and leptin.

13
Fatty liver index trajectories

The lack of an accurate, non-invasive, easily accessible and affordable diagnostic test
has been an important factor limiting research regarding fatty liver in the general
population. The FLI is an algorithm based on WC, BMI, TG and GGT. The index was
initially developed to detect fatty liver

26

. It is a reliable tool for fatty liver research,

recommended by a group of European Societies for diagnosis of fatty liver in
epidemiological studies 14 and has been validated in the Raine Study cohort 27. The FLI
has been shown to have the best calibration performance compared to other prediction
models attempting to identify fatty liver disease. This suggests that the FLI has a good
ability to predict the risk of fatty liver among study participants at the individual level.
We hypothesised that FLI is useful as a continuous variable in repeated measurements
of longitudinal data to detect changes in fatty liver risk. To answer our research question,
we applied a trajectory model to describe the natural history of fatty liver over eight
years in Raine Study participants from adolescence (14 years) to young adulthood (22
years) using the FLI (Figure 1).

Covariate assessment
At each follow-up, children’s medical status were reported, and the following variables
collected. The primary caregivers of the participants were asked to report their annual
family income (in Australian dollars) at the 14-year follow-up (2003-2006) and
categorised as: <$ 30,000, $30001-50,000, $50001-78,000, and >$78,000. Also, at the
14-year follow-up, hours of physical activity per week were assessed through the
International Physical Activity Questionnaire (IPAQ). Participants reported the time
and frequency spent in exercising vigorously during physical education at school and
outside school. Screen time, including time spent using a computer, was collected
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through a questionnaire with response options from ‘none at all’ to ‘4 hours or more’
per day by participants’ primary caregivers.

Statistical analysis

Continuous descriptive data with normal distributions are presented as means ±
standard deviation (SD); non-normally distributed data are reported as medians and
interquartile ranges (IQRs).

Trajectories were estimated with group-based trajectory modelling (GBTM)

28

. The

trajectories were derived by modelling the FLI as a function over time (participants’
age at each follow-up measurement). Data requirements for participants in the model
were limited to having FLI data at the 14-year follow-up and at least one other followup (17, 20, or 22 years).

The best-fit model was based on the Bayesian Information Criterion (BIC) and the
presence of a minimum of 5% of participants per trajectory to ensure stable estimates
28,29

. After setting the number of trajectories and non-significant quadratic and cubic

terms were removed, the best optimal model was estimated by fit indices, pragmatic
evaluation, and clinical relevance. Fit indices included BIC and Akaike's information
criterion (AIC) with the lower the indices, the better the model fit 28 (supplemental text
3 Table A1). After the model was built, we tested its accuracy with the conditions
suggested by Nagin 28: the average posterior probability of assignment of each group
was 0.7 or higher; the odds of correct classification was 5.0 or higher; the proportion of
samples allocated to a particular group was close to the proportion estimated by the
model, and the 99% confidence interval for the estimated proportion was reasonably
narrow (supplemental text 3).
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Dietary fat exposures were converted to Z-scores in the log multinominal regression
models to obtain appropriate clinical interpretations. Log multinominal regression
analyses were conducted to estimate relative risks (RRs) and 95% confidence intervals
(CIs) with multiple attributes 30 of three distinct FLI trajectories (stable-high FLD risk
SH; low-high FLD risk LH) using the “stable-low FLD risk, SL” trajectory groups as a
reference. RR and 95% confidence intervals (CIs) were reported for each FLI trajectory
as follows: model 1 adjusted for total energy intake plus dietary misreporting; model 2
adjusted for model 1 plus sex; model 3 adjusted for model 2 plus computer viewing,
and family income. We used the standard multivariate model instead of nutrient density
for energy adjustment. This is because if nutrient density is used, nutrient intake will
be confounded by total energy intake (in the opposite direction) as it is divided by total
energy when the disease is also associated with total energy intake. BMI was not in the
model because the already adjusted covariates such as total energy intake, dietary
misreporting and BMI were highly correlated, and additional adjustment for BMI could
not be fitted to the model. All analyses were performed using Stata 15.0 for Windows
(Stata Statistical Software: College Station, Tx, USA). P values < 0.05 were regarded
as statistically significant.

Results

Our study population was derived from comprised 985 Gen2 adolescents aged 14 years.
Participant characteristics at the 14-year follow-up are presented by different FLI
trajectory groups in Table 1. The overall characteristics of the cohort showed 52% were
male, 89% were of Caucasian maternal race, and 42% of the cohort had an annual
family income over $70,000 at baseline. Since FLI has no interaction with sex 27, the
entire population with no gender breakdown is included in the trajectory analysis model.
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From the 985 eligible participants, three different FLI trajectories were identified
(Figure 1) (supplementary text 2) and labelled as “stable low fatty liver risk, SL”
(79.1%, N=782, trajectory 1), “low to high fatty liver risk, LH” (13.9%, N=132,
trajectory 2), and “stable high fatty liver risk, SH” (7%, N=71, trajectory 3). The rising
FLI trajectory indicates an increased risk of fatty liver for the individual in the SH group.
The majority of participants (79%, N=782) maintained a SL fatty liver risk from 14 to
22 years, while 7% (N=71) and 14% (N=132) were categorised in SH and LH fatty
liver risk groups, respectively. For the demographic characteristics in the trajectory
groups at baseline (Table 1), the SH group had the highest proportion of males (57.8%),
Caucasian maternal race (93.0%), and annual family income less than $35000 (50.7%).
The SH group also had higher serum ALT, GGT, triglycerides, insulin and lower HDLcholesterol, that may represent increased cardiometabolic risk. Lifestyle characteristics,
such as dietary misreporting and BMI, were significantly different between the three
trajectory groups. In the SH group, nearly 46% were underreporters as identified from
the dietary misreporting analysis. The majority of subjects in the SL and LH groups
were categorised as within a healthy weight range, whereas 83% of participants in the
SH group were categorised as overweight. Among the laboratory biochemical
indicators shown in Table 1, the SH group had the highest mean levels of all the
biomarkers other than AST and HDL-C.

The baseline dietary fat intake characteristics are shown in Table 2 for plausible
reporters only. Considering the group variations in energy requirements, the percentage
of energy intake from specific TFA, SFA and MUFA categories of dietary fats are also
reported. Energy intake from the fat categories LCPUFA, n-3 and n-6 are not shown
because energy levels of these nutrients were very low. All indicators of fat intake
characteristics (including absolute value and percentage of energy) were non-normally
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distributed. For most indicators, except for n-3 and LCPUFA, the SH risk group had
the highest median intake of all dietary fats and percentage of energy compared to the
SL and LH groups. For n-3 and LCPUFA, the LH group had the highest median intake
level (total n-3 1.3 g/day and LCPUFA 288 mg/day). Except for SFA, the absolute
value of most fat categories (TFA, PUFA and MUFA) showed the same trend as the
percentage of energy. However, for SFA, the median absolute value of SFA in the LH
group is moderate but accounts for the lowest median energy percentage (absolute value:
41.5 (g/day), energy percentage: 14.4%).

Table 3 shows the results from multinomial analysis of the correlation between baseline
dietary fats and FLI trajectories with the SL group as the reference group for each
dietary fats exposure. The RR of the multinomial analyses shows LCPUFA, n-6 and N3: N6 at baseline (14 years) were significantly associated with the FLI trajectories after
adjusting for all covariates. LCPUFA in the LH group relative to the SL group has a
RR of 1.27 (95% CI 1.10-1.48) in model 3. Compared to the SL group, n-6 and N-3:
N6 in the SH group has RRs of 1.34 (95% CI 1.02-1.76) and 1.10 (95% CI 1.03-1.16)
respectively in the final model.

Supplementary Table 3 shows that the intake of dietary fats was lower in the SH group
compared to that of the LH and SL groups. This may be due to the 46.5% underreporting in the SH group (Table 1). Nevertheless, this relationship is different in n-3
fatty acids and LC-PUFA with the intake of LH group the highest, while the intake of
SH group is lower than that of LH group. Supplementary Table 5 shows the RR values
for the three LC-PUFA (DPA, EPA and DHA) incorporated in the same regression
model. We found that all three lose their significant association with the LH group,
while EPA maintains its original risk association trend with the LH group (RR: model
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3 1.20 (0.74-1.95). Supplementary Table 6 indicates the component characteristics of
LCPUFA intake (plausible reporters only), with DPA being the main component of
LCPUFA intake and the highest median level of LCPUFA intake in the LH group
among the three trajectory groups.

Discussion

The primary aim of this study was to investigate the prospective association of dietary
fats on FLI trajectories, hence fatty liver risk, longitudinally. We identified three
different fatty liver index trajectories from a young population in Western Australia and
observed a dietary fat intake relationship with these trajectories. The majority of
participants were in the SL group, with a sustained low FLI. The SH group had FLI at
a relatively persistent high level, while the LH group changed from low to high risk for
FLD during follow up. After controlling for total energy, dietary misreporting, sex,
computer viewing and family income, intake of LCPUFA, n-6 and N6: N3 at baseline
were significantly associated with prospective and longitudinal FLI trajectories over
eight years of follow-up.

Our study provides a unique insight into the relationship of longitudinal patterns of
dietary fat intake on the natural history of fatty liver from adolescence to young
adulthood. We show that fatty liver development follows specific trajectories over time
in young populations. FLI, as a predictor of fatty liver, has been widely used in
epidemiological studies as an alternative diagnostic tool for fatty liver. The prevalence
of datty liver based on FLI in 17-year-old adolescents in the Raine Study was 11.6%27
Meta-analyses have shown that the prevalence of FLD or NAFLD was 11.3% in
children 10-14 years 31, 17.3% in adolescents 15-19 years 32 and 24% in young adults
18-35 years

33

. Our FLI trajectory data show a similar fatty liver disease trend from
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adolescents to young adults. These findings are worthy of highlighting, since the
chronicity and severity of fat accumulation in the liver is associated with subsequent
risk of type II diabetes and cirrhosis later in life 2. It also demonstrates the importance
of the transition from adolescence to young adulthood as a critical period for health
promotion and health interventions to reduce the impacts of chronic liver disease and
cardiometabolic risk.

Our main finding is that a diet high in n-6 fatty acids or a high N6: N3 ratio at 14 years
of age associates with an increased risk of FLD from adolescence to young adulthood.
This implicates n-6 fatty acids as a potential risk factor in the development of FLD.
Moreover, these findings are similar to previous studies in which cross-sectional
associations between N6: N3 and obesity34 and fatty liver risk

35

were observed. In a

typical Western diet, the ratio of N6: N3 is usually 15-16:1, rather than the
recommended 1-4:1, that is considered the healthy range 36. Nuts and seeds are rich in
n-6, which is why large amounts of n-6 can be found in refined vegetable oils such as
palm oil and sunflower oil and foods cooked with these vegetable oils. Vegetable oils
are a widely used source of fatty acids in the food industry for processed snacks, fast
foods, cakes and cured meats that are also rich in n-6 and high in ratio of N6: N337.
These findings are biologically plausible because desaturase and elongase tend to
metabolise n-3, thereby competing with n-6 and reaching a dynamic equilibrium. Thus,
in the presence of large amounts of n-6 PUFA in the diet, its metabolites such as
arachidonic acid and its derivatives disrupt the original anti/pro-inflammatory
imbalance by increasing thrombosis and inflammation 38,39.

Another interesting finding suggested that LCPUFA, especially EPA, could be a risk
factor for fatty liver. In fact, even though EPA and DHA are often grouped together as
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omega-3 fatty acids and are thought to be beneficial for lipid metabolism, differences
are being reported regarding the mechanisms of EPA versus DHA
fatty acid study uing mice as subjects

40,44

40-43

. In a dietary

, EPA was found to be associated with

elevated hepatic inflammatory markers and poorer performance in reducing liver fat or
improving liver metabolism. A more credible human RCT study showed that EPA
supplementation was weaker than DHA in lowering serum inflammatory markers and
blood lipids 45. However, so far there are no data from human studies highlighting this
difference in hepatic lipid metabolism. A human epidemiological study from a
prospective nested case-control cohort found a positive risk association (although not
statistically significant) of EPA with the risk of Crohn's disease 46. This is similar to the
findings in our study, where only EPA appeared to exhibit a positive trend (not
statistically significant) with increased FLD risk (Supplementary Table 5). The reason
for this is unclear, although basic research suggests that generally, EPA and DHA
down-regulate the inflammatory response, though perhaps less effectively than DHA
43,45

. There are also studies reporting that EPA can be pro-inflammatory 44. Otherwise,

for the same food source, EPA and DHA should be observed to have an isotropic effect
rather than an opposite effect (Supplementary Table 5). Another possible reason is the
different food sources of dietary fats. EPA is available from a wider range of food
sources, such as edible oils, rather than being limited to oily fish alone. The process of
dietary data collection resulted in the association of EPA with potential risk factors thus
making a spurious association in the analysis. This suggests that more research should
be done on dietary fatty acid sources in this population, and if DHA and EPA dietary
sources are different, differences in their utility performance could potentially also be
explained.
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Our study validates findings in nutritional epidemiology regarding dietary misreporting,
which is often associated with BMI status; educational level; and age

47,48

and can be

especially vulnerable to bias when we evaluate dietary-metabolic disease associations.
Differences in dietary characteristics between plausible (table 2) and implausible
(supplementary table 1) populations may result from overweight and obese people
under-reporting their intake of dietary fats 49.

Strengths and limitations

To our knowledge, this study is the first to explore the association between dietary fat
intake of adolescents with the longitudinal natural development of fatty liver into young
adulthood. The strengths of our study include the use of data from a large prospective
cohort which can prospectively collect dietary information to minimise recall bias
representative of the general adolescent and young adult population, a focus on the
natural history of FLD risk from adolescence to young adulthood and use of an
objective and validated fatty liver screening tool for longitudinal data analysis over
eight years.

Our study has several limitations. First, proper interpretation of the results of the study
requires consideration of measurement errors in self-reported dietary data, unavoidable
when using an FFQ 50. We minimised this impact by applying a less biased instrument
(3-day food record) and performing an internal calibration of the FFQ data

17

finding

relative validity. Dietary misreporting is introduced into the analysis as a covariate
factor to achieve better statistical modelling. The energy adjustment method was also
applied to minimise the impact of FFQ measurement errors in statistical modelling.
Second, our data come from a pregnancy cohort and participants were recruited (Gen
2) predominantly in a relatively concentrated age range, so it is not possible to
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determine whether our findings are applicable to other populations. Finally, dietary
fatty acid exposure in our study was assessed only at age 14 years. Dietary habits during
adolescence may change over time. The use of only one prospective assessment of
dietary intake is a limitation of our study. We have also not accounted for degrees of
physical activity.

Our study reveals that aspects of dietary fat intake are associated with the future risk of
FLD in young populations. While dietary fat consumption at age 14-years is unlikely
to independently lead to an increased risk of FLD eight years later, dietary habits
established during adolescence are likely to persist into adulthood, including into the
reproductive years

51

. Interestingly, we examined changes in the trajectory of dietary

patterns from adolescence to early adulthood (from 14, 17 to 20 years of age) in the
Raine study Gen2 population52 and found that 21% of men consuming mainly the
Western Dietary Pattern Score had a stable, significant growth trajectory over time
suggesting that dietary patterns established during adolescence are likely to persist into
early adulthood, especially among males. This study supports the idea that specific
populations can still benefit from early dietary interventions. Therefore, family diet
education or intervention may be a viable way to prevent or reduce the rising prevalence
of fatty liver among younger populations.

Future nutritional epidemiological studies should focus on the pathways by which n-6
fatty acids are associated with FLD, such as the mediation of inflammatory factors.
Additionally, a focus on risk factors for the development of FLD in potential risk
populations is recommended, such as validating the relationships between EPA and
metabolism-related outcomes in larger populations.

Conclusions

23
Our study shows that some aspects of fatty acid intake in early adolescence are
associated with FLD trajectories from adolescence to young adulthood, highlighting a
critical period for forecasting the development or perpetuation of fatty liver. Diets to
improve fatty acid balance in the diet to protect against FLD need to be promoted that
include a low N6: N3 fatty acid diet and fewer foods high in n-6.

24
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Table 1: Characteristics of study population at baseline (14 years) by trajectory groups
from 14 to 22 years in the Raine Study
Characteristic

SL group

LH group

SH group

Total

782

132

71

985

Sex † (proportion of males) (%)

50.1

56.8

57.8

51.6

Maternal race ‡

87.6

91.7

93.0

88.5

N=770

N=131

N=70

N=971

<35000

19.5

23.7

50.7

22.4

35000-70000

36.8

35.9

27.9

35.9

>70000

43.8

40.5

21.4

41.7

Underreporting

22.3

29.6

46.5

25.0

Plausible reporting

66.2

62.1

52.1

64.7

Overreporting

11.5

8.3

1.4

10.3

Underweight

3.1

0

0

2.4

Healthy weight

83.6

40.0

2.8

72.0

Overweight

11.8

3.8

14.1

16.0

Obese

1.5

18.2

83.1

9.6

N=628

N=102

N=51

N=781

N

General

(proportion with Caucasian mother) (%)

Annual family income

at baseline (%) **

Child lifestyle at 14 years

Dietary Misreporting (%)**

BMI (%)**

Physical activity (%)

29
once month or less

9.7

9.8

9.8

9.7

1-3 times per week

57.2

53.9

66.7

57.4

4+ times per week

33.1

36.3

23.5

32.9

N=778

N=135

N=70

N=983

< 2 h per day

80.2

71.2

75.7

78.5

2–4 h per da

13.5

18.2

17.2

14.5

> 4 h per day

6.3

10.6

7.1

7.0

ALT (U/L) **

16.19(6.77)

17.74(10.38)

23.06(10.35)

16.89(7.84)

AST (U/L) **

46.58(2.51)

46.35(2.67)

45.90(2.67)

46.50(2.52)

GGT (U/L) **

11.10(4.31)

11.77(3.72)

16.55(6.75)

11.58(4.67)

Total cholesterol (mmol/L)

4.17(0.68)

4.09(0.76)

4.30(0.81)

4.17(0.70)

Triglycerides (mmol/L) **

0.95(0.43)

1.08(0.45)

1.51(1.18)

1.01(0.54)

Insulin (mU/L) **

11.16(7.40)

13.01(6.27)

22.91(14.13)

12.25(8.49)

HDL‐C (mmol/L) **

1.44(0.32)

1.29(0.28)

1.13(0.01)

1.39(0.32)

LDL‐C (mmol/L)

2.30(0.61)

2.31(0.66)

2.47(0.71)

2.31(0.63)

Computer viewing (%)

Biochemistry (mean and standard
deviation)

Footnote:

ALT: alanine transaminase; AST: aspartate aminotransferase; BMI: body mass index;
FFQ: food frequency questionnaire; GGT: gamma‐glutamyl transferase; HDL-C: highdensity lipoprotein cholesterol; LDL-C: low‐density lipoprotein cholesterol; LH: low
risk to high risk; SH: stable high risk, SL: stable low risk;

The results are presented as means and standard deviations except for percentages.

30
* for P<0.05 and ** for P<0.01 for the difference within groups.
†； baby's sex was recorded at birth.

‡: Maternal race data were collected at study recruitment 16-20 weeks gestation
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Table 2 FFQ dietary fat intake characteristics of participants at age 14 years presented
as median and interquartile ranges (Q1, Q3) (Plausible reporters only) in the Raine
Study
Dietary fats at 14 years (g/day)

SL group

LH group

SH group

P-value

N

518

82

37

TFA

89.9(75.9,104.6)

98.3(79.3,113.8)

102.1(88.0,117.3)

0.65

energy from TFA (%)

34.9(31.5,38.6)

35.2 (31.7,39.0)

36.3(32.1,39.3)

0.75

SFA

39.2(32.3,47.2)

41.5(32.7,49.4)

44.6(38.1,53.3)

0.77

energy from SFA (%)

15.3(13.1,17.4)

14.4(12.3,16.9)

15.5(14.2,17.7)

0.15

PUFA

12.6(9.7,17.7)

16.1 (11.5,20.2)

16.8(10.7,20.3)

0.10

energy from PUFA (%)

5.1(3.8,6.3)

5.7(4.0,7.1)

5.8(3.9,7.0)

0.12

MUFA

31.2(26.1,36.1)

34.8(27.4,42.3)

34.8(30.5,40.0)

0.55

energy from MUFA (%)

12.1(10.7,13.3)

12.3(10.6,14.1)

12.4(11.1,13.4)

0.32

n‐3

1.2(1.0,1.5)

1.3(1.0,1.8)

1.2(1.1,1.5)

0.05

LCPUFA (mg/day)

231.0(164.8,306.9)

288.4(193.3,414.9)

237.0(167.2,301.1)

0.01

n-6

10.3(7.8,14.6)

12.9(8.8,17.2)

14.5(9.2,17.2)

0.08

N6: N3

9.1(6.6,11.9)

9.7(6.8,12.5)

12.0(7.1,13.5)

0.01

Footnote:
DHA: docosahexaenoic acid; DPA: docosapentaenoic acid; EPA: eicosapentaenoic
acid; LCPUFA: long-chain fatty acids (EPA + DPA + DHA); LH: low risk to high risk;
MUFA: monounsaturated fats; n‐3: omega-3 fatty acids; N6: N3: the ratio of total n-6
and total n-3 fatty acids; n-6: omega-6 fatty acids; PUFA: polyunsaturated fats; SFA:
saturated fats; SH: stable high risk; SL: stable low risk; TFA: total fats;
The results are presented as median and interquartile ranges (Q1, Q3).
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Table 3. Log multinomial regression models for each dietary fat (Z-score) at 14 years
and different fatty liver index trajectories in the Raine Study (stable low risk as the
reference group).
Dietary fats (z-score) at 14 years

Low to high (LH)

P-value

risk group

Stable high (SH)

P-value

risk group

Total fat z-score

Model 1 (N=985)

0.94(0.64-1.37)

0.764

1.43(0.80-2.55)

0.225

Model 2 (N=985)

0.98(0.68-1.43)

0.920

1.58(0.90-2.78)

0.110

Model 3 (N=966)

1.01(0.70-1.46)

0.949

1.55(0.90-2.65)

0.112

Model 1

0.80(0.61-1.04)

0.100

1.10(0.74-1.63)

0.630

Model 2

0.82(0.63-1.08)

0.158

1.19(0.81-1.75)

0.370

Model 3

0.84(0.65-1.11)

0.225

1.17(0.83-1.66)

0.361

Model 1

1.14(0.94-1.37)

0.186

1.26(0.95-1.65)

0.107

Model 2

1.14(0.94-1.38)

0.191

1.28(0.96-1.71)

0.090

Model 3

1.15(0.95-1.39)

0.164

1.20(0.89-1.61)

0.228

Model 1

1.15(0.81-1.61)

0.438

1.44(0.85-2.42)

0.173

Model 2

1.15(0.82-1.60)

0.424

1.43(0.88-2.33)

0.153

Model 3

1.16(0.84-1.62)

0.365

1.56(0.96-2.54)

0.074

Model 1

1.14(0.97-1.33)

0.119

0.86(0.61-1.19)

0.362

Model 2

1.14(0.97-1.33)

0.112

0.89(0.64-1.23)

0.482

Saturated fat z-score

Polyunsaturated fat z-score

Monounsaturated fats z-score

Total omega‐3 z-score
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Model 3

1.13(0.97-1.32)

0.126

0.99(0.71-1.38)

0.942

Model 1

1.28(1.11-1.47)

<0.001

0.96(0.73-1.25)

0.744

Model 2

1.28(1.11-1.47)

0.001

0.91(0.70-1.18)

0.485

Model 3

1.27(1.10-1.48)

0.001

0.96(0.75-1.24)

0.782

Model 1

1.10(0.91-1.32)

0.319

1.33(1.05-1.70)

0.019

Model 2

1.10(0.92-1.33)

0.297

1.38(1.08-1.78)

0.010

Model 3

1.12(0.93-1.34)

0.240

1.34(1.02-1.76)

0.035

Model 1

0.99(0.94-1.03)

0.593

1.11(1.05-1.17)

<0.001

Model 2

0.99(0.95-1.04)

0.641

1.12(1.06-1.19)

<0.001

Model 3

0.99(0.95-1.04)

0.709

1.10(1.03-1.16)

0.003

long-chain fatty acids

(EPA + DPA +DHA) z-score

Total omega‐6 z-score

Total n‐6: total n:3 z-score

Footnote:
DHA: docosahexaenoic acid; DPA: docosapentaenoic acid; EPA: eicosapentaenoic
acid; LH: low risk to high risk; SH: stable high risk; SL: stable low risk.
The results are presented as means and standard deviations.
Model 1 adjusted for total energy+ misreporting
Model 2 adjusted for 1+ sex
Model 3 adjusted for 2+ computer viewing + family income.

